Stephen From is the founder of EyeGate Pharmaceuticals. EyeGate Pharmaceuticals has raised $31M in total funding. Latest round: Series C.
Stephen From is the President and Chief Executive Officer of EyeGate Pharma, a specialty pharmaceutical company focused on delivering therapeutics for serious ocular diseases. Under his leadership, EyeGate Pharma secured $15 million in Series C venture funding to advance two Phase II clinical studies for uveitis and dry eye.
Full founder directory · Investor directory · Company funding database · Fundraising library